BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3937219)

  • 1. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
    Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
    Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
    Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
    Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.
    Hellgren M; Egberg N; Eklund J
    Intensive Care Med; 1984; 10(1):23-8. PubMed ID: 6559831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
    Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
    Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous type I plasminogen deficiency.
    Mingers AM; Heimburger N; Zeitler P; Kreth HW; Schuster V
    Semin Thromb Hemost; 1997; 23(3):259-69. PubMed ID: 9255907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated intravascular coagulation (DIC) induced by liquoid (polyanetholsulfonate) in the rat. V. Effects on circulating fibronectin.
    Cerda J; Urizar RE; Conran R; Blumenstock FA; Kaplan JE; Malik AB; Simon R
    Br J Exp Pathol; 1986 Oct; 67(5):623-8. PubMed ID: 3024691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Absence of fibronectin in a 40-day-old child who died as a result of septicemia with disseminated intravascular coagulation].
    Blanco A; Solís P; Guisasola JA; Arranz E; Tellería JJ; Blanco C
    Sangre (Barc); 1989 Feb; 34(1):59-62. PubMed ID: 2711287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin in severe sepsis.
    Stevens LE; Clemmer TP; Laub RM; Miya F; Robbins L
    Surg Gynecol Obstet; 1986 Mar; 162(3):222-8. PubMed ID: 3082023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated intravascular coagulation (DIC).
    Mammen EF
    Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
    Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
    J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.